Immune complex mediated reaction
First, the core concept here is Type III hypersensitivity, which is indeed immune complex mediated. I need to explain that immune complexes form when antigens bind to antibodies, leading to inflammation and tissue damage. The key here is understanding the mechanism of how these complexes deposit in tissues and activate the complement system.
The correct answer should be Type III hypersensitivity. Let me confirm that. Type III involves immune complexes, like in conditions such as serum sickness or systemic lupus erythematosus. The complexes get trapped in small vessels, causing inflammation. So the explanation would detail how these complexes activate complement and recruit neutrophils, leading to tissue injury.
Now, the wrong options. Let's assume the options are Type I, II, III, IV. The user probably had those. So Type I is IgE-mediated, like anaphylaxis. Type II is antibody-mediated against cell surfaces, like hemolytic anemia. Type IV is cell-mediated, like contact dermatitis. Each of these is a different hypersensitivity type, so explaining why they don't fit is important.
Clinical pearl: Remember that Type III reactions are associated with immune complex deposition and complement activation. Classic examples help here. Also, the student should note the difference in the immune cells involved in each type.
Need to make sure the explanation is concise, within the character limit. Let me structure each section as required, using bold for key terms and avoiding markdown headers. Keep the language clear and precise for a medical student preparing for exams like NEET PG or USMLE.
**Core Concept**
Immune complex-mediated reactions fall under **Type III hypersensitivity**, where antigen-antibody complexes deposit in tissues, triggering inflammation via complement activation and neutrophil recruitment. This mechanism underlies diseases like systemic lupus erythematosus (SLE) and serum sickness.
**Why the Correct Answer is Right**
**Type III hypersensitivity** occurs when soluble immune complexes (IgG, IgM, or IgA with antigens) deposit in small vessels, glomeruli, or joints. These complexes activate the **classical complement pathway**, recruiting neutrophils and releasing proteases, reactive oxygen species, and cytokines. This causes tissue damage seen in conditions like **post-streptococcal glomerulonephritis** or **rheumatoid arthritis**.
**Why Each Wrong Option is Incorrect**
**Option A:** *Type I hypersensitivity* involves IgE-mediated mast cell degranulation (e.g., anaphylaxis).
**Option B:** *Type II hypersensitivity* involves antibody-mediated cell destruction (e.g., hemolytic anemia).
**Option D:** *Type IV hypersensitivity* is cell-mediated (e.g., tuberculin reaction), driven by T-cells and macrophages.
**Clinical Pearl / High-Yield Fact**
Remember **"Type III = Immune Complex + Complement + Neutrophils"**. Classic exam clues include **vasculitis**, **glomerulonephritis**, or **arthritis** in diseases like SLE or PAN. Avoid confusing with IgE-mediated (